Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 003520268 approvals34 trials

YUNGJIN PHARM. CO., LTD

Official website

Founded in 1962 and listed on the KOSPI in 1973, Yungjin Pharm is a KT&G Group pharmaceutical affiliate exporting antibiotic injectables and APIs and operating a CMO business.

As of 2026-10-10, YUNGJIN PHARM. CO., LTD has 2 Korean MFDS device approvals, 266 Korean MFDS drug approvals, 6 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Health drinksDrink-type pharmaceutical
  • AntibioticsAntibiotic
  • Nutritional infusion solutionsNutritional infusion
  • Quasi-drugsQuasi-drug

Regulatory approvals

data.go.kr

266 Korean MFDS drug approvals · 1973–2026 / 2 Korean MFDS device approvals · 2016

  • MFDS drugAtoxetine Tab. 20mg(Atomoxetine Hydrochloride)2026-08-27
    Drug · Prescription · Approval202602513
  • MFDS drugAtoxetine Tab. 40mg(Atomoxetine Hydrochloride)2026-08-10
    Drug · Prescription · Approval202602321
  • MFDS drugColmin nose Soft Cap.2026-02-04
    Drug · OTC · Notification202600316
  • MFDS drugFULLMECOOL SUSPENSION FOR NEBULIZER2026-01-16
    Drug · Prescription · Approval202600153
  • MFDS drugColmin-S Syrup2025-08-06
    Drug · OTC · Notification202502045
  • MFDS drugColmin-S Tab.2025-06-26
    Drug · OTC · Notification202501581
  • MFDS drugNeoblue5 inj.2025-06-18
    Drug · Prescription · Approval202501498
  • MFDS drugNintebro Tab. 100mg2024-12-31
    Drug · Prescription · Approval202403105
  • MFDS drugDemenduo tablet 10/20mg2024-12-23
    Drug · Prescription · Approval202403046
  • MFDS drugNintebro Tab. 150mg2024-12-12
    Drug · Prescription · Approval202402952
  • MFDS drugGinkamin Tab. 240mg2024-11-05
    Drug · OTC · Notification202402606
  • MFDS drugAsrazole Cap. 100/5mg2024-09-30
    Drug · Prescription · Approval202402348
Show 68 more
  • MFDS drugImpac Speed Sol.2024-01-30
    Drug · OTC · Notification202400223
  • MFDS drugYungjindadu XR Tab. 10/500mg2023-06-21
    Drug · Prescription · Approval202301895
  • MFDS drugDapflo Tab. 10mg2023-01-31
    Drug · Prescription · Approval202300414
  • MFDS drugDapflo M SR Tab. 10/500mg2023-01-31
    Drug · Prescription · Approval202300428
  • MFDS drugDapflo M SR Tab. 10/1000mg2023-01-31
    Drug · Prescription · Approval202300429
  • MFDS drugRaceca Cap. 100mg(racecadotril)2023-01-18
    Drug · Prescription · Approval202300287
  • MFDS drugYungjindaduXR10/1000mg2023-01-06
    Drug · Prescription · Approval202300152
  • MFDS drugAripizin Tab. 1mg2022-12-23
    Drug · Prescription · Approval202204615
  • MFDS drugTalimin SR Tab.2022-12-21
    Drug · Prescription · Approval202204557
  • MFDS drugAripizin Tab. 2mg2022-12-07
    Drug · Prescription · Approval202204409
  • MFDS drugYungJin Olanzapine Tablets 10mg2022-09-19
    Drug · Prescription · Approval202203600
  • MFDS drugYungJin Olanzapine Tablets 5mg2022-09-19
    Drug · Prescription · Approval202203601
  • MFDS drugTeliptin M SR Tab. 20/1000mg2022-07-01
    Drug · Prescription · Approval202202704
  • MFDS drugTeliptin M SR Tab. 10/500mg2022-07-01
    Drug · Prescription · Approval202202705
  • MFDS drugTeliptin M SR Tab. 10/750mg2022-07-01
    Drug · Prescription · Approval202202706
  • MFDS drugBupensol inj.2022-06-10
    Drug · Prescription · Notification202202410
  • MFDS drugRabenew Tabs 20/500mg2022-01-27
    Drug · Prescription · Approval202200467
  • MFDS drugYungJin Buspirone Tablets 5mg2022-01-18
    Drug · Prescription · Approval202200672
  • MFDS drugYungJin Buspirone Tablets 10mg2022-01-11
    Drug · Prescription · Approval202200673
  • MFDS drugSiDapflo Tab. 10/100mg2022-01-04
    Drug · Prescription · Approval202200048
  • MFDS drugRabenew Tabs. 10/500mg2021-12-31
    Drug · Prescription · Approval202108204
  • MFDS drugXarex 2.5mg Tab.2021-12-24
    Drug · Prescription · Approval202108105
  • MFDS drugPancron F Tab.2021-11-23
    Drug · OTC · Notification202107591
  • MFDS drugXarex 10mg Tab.2021-07-14
    Drug · Prescription · Approval202105341
  • MFDS drugXarex15mg Tab.2021-07-14
    Drug · Prescription · Approval202105342
  • MFDS drugXarex20mg Tab.2021-07-14
    Drug · Prescription · Approval202105343
  • MFDS drugPelps Tab.2021-05-24
    Drug · Prescription · Approval202104053
  • MFDS drugYUNGJIN Teneligliptin Tab. 20mg2021-04-01
    Drug · Prescription · Approval202102859
  • MFDS drugAtorvazin Plus Tab. 10/40mg2021-02-18
    Drug · Prescription · Approval202101618
  • MFDS drugAtorvazin Plus Tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101619
  • MFDS drugAtorvazin Plus Tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101620
  • MFDS drugOmaron Mini Soft Cap.2020-12-14
    Drug · Prescription · Approval202008758
  • MFDS drugYungjin Zopiclone Tab. 1mg2020-12-14
    Drug · Prescription · Approval202008746
  • MFDS drugYungjin Zopiclone Tab. 2mg2020-12-14
    Drug · Prescription · Approval202008747
  • MFDS drugYungjin Zopiclone Tab. 3mg2020-12-14
    Drug · Prescription · Approval202008748
  • MFDS drugDapto Inj. 500mg2020-10-14
    Drug · Prescription · Approval202007027
  • MFDS drugDapto Inj. 350mg2020-10-14
    Drug · Prescription · Approval202007028
  • MFDS drugYUNGJIN Melatonin PR Tab. 2mg2020-09-22
    Drug · Prescription · Approval202006551
  • MFDS drugYungjin Dapagliflozin Tab. 10mgRevoked2020-07-23
    Drug · Prescription · Approval202005356
  • MFDS drugYungjin Dapagliflozin Tab. 5mgRevoked2020-07-23
    Drug · Prescription · Approval202005357
  • MFDS drugQutiapine Tab. 50mg2020-06-29
    Drug · Prescription · Approval202004751
  • MFDS drugQutiapine Tab. 12.5mg2020-06-29
    Drug · Prescription · Approval202004752
  • MFDS drugTamrosin SR Tab. 0.4mg2020-04-24
    Drug · Prescription · Approval202003013
  • MFDS drugGaspiran SR Tab. 15mg2020-04-17
    Drug · Prescription · Approval202002748
  • MFDS drugNocid Tab.2020-04-14
    Drug · OTC · Notification202002642
  • MFDS drugYungjin Famotidine Tab. 20mgRevoked2020-02-18
    Drug · Prescription · Approval202001107
  • MFDS drugIvy Pro SyrupRevoked2020-02-04
    Drug · OTC · Notification202000605
  • MFDS drugYunjin Bromelain Enteric Coated Tab. 100mg2019-10-02
    Drug · OTC · Notification201907042
  • MFDS drugTelmirosu Tab. 80/5mgRevoked2019-09-30
    Drug · Prescription · Approval201906980
  • MFDS drugTelmirosu Tab. 40/20mgRevoked2019-09-30
    Drug · Prescription · Approval201906981
  • MFDS drugTelmirosu Tab. 40/10mgRevoked2019-09-30
    Drug · Prescription · Approval201906982
  • MFDS drugTelmirosu Tab. 40/5mgRevoked2019-09-30
    Drug · Prescription · Approval201906983
  • MFDS drugTelmirosu Tab. 80/20mgRevoked2019-09-30
    Drug · Prescription · Approval201906984
  • MFDS drugTelmirosu Tab. 80/10mgRevoked2019-09-30
    Drug · Prescription · Approval201906985
  • MFDS drugAtorvazin Tab. 20mg2019-09-11
    Drug · Prescription · Approval201906438
  • MFDS drugTiasen Inj.2019-07-12
    Drug · Prescription · Notification201904720
  • MFDS drugYungjin Tianeptine Tab.Revoked2019-07-12
    Drug · Prescription · Approval201904719
  • MFDS drugThiocsen Inj.2019-07-09
    Drug · Prescription · Notification201904638
  • MFDS drugZincen Inj.Revoked2019-07-02
    Drug · Prescription · Notification201904513
  • MFDS drugGinkamin Tab. 80mg2019-06-25
    Drug · OTC · Notification201904346
  • MFDS drugYungJin Oseltamivir Suspension Powder 6mg/mLRevoked2019-06-10
    Drug · Prescription · Approval201903804
  • MFDS drugYungjin Cilostazol SR Cap. 100mg2019-05-31
    Drug · Prescription · Approval201903663
  • MFDS drugYungjin Cilostazol SR Cap. 200mg2019-05-31
    Drug · Prescription · Approval201903664
  • MFDS drugYungjin Aminophen Soft Cap. 325mgRevoked2019-05-28
    Drug · OTC · Notification201903455
  • MFDS drugClacid Tab. 500mgRevoked2019-05-23
    Drug · Prescription · Approval201903343
  • MFDS drugDenonex Inj.2019-05-20
    Drug · Prescription · Approval201903226
  • MFDS drugYungjin Fluoxetine Cap. 20mg2019-05-09
    Drug · Prescription · Approval201903001
  • MFDS drugYungjin Fluoxetine cap. 10mg2019-05-02
    Drug · Prescription · Approval201902843

Showing the 80 most recent of 268 records.

Clinical trials

data.go.kr

34 MFDS clinical trial authorisations · 2014–2026 (Bioequivalence 20 · Phase 1 13 · Phase 2 1)

  • BioequivalenceYPI-0142026-05-28

    2 trial sites

  • Phase 1YPG-0432026-03-31

    2 trial sites

  • Phase 1YPG-0142025-09-18

    2 trial sites

  • BioequivalenceYPG-0422025-07-17

    2 trial sites

  • Phase 1YPG-0432025-07-16

    2 trial sites

  • Phase 1YPG-0402024-10-22

    2 trial sites

  • Phase 1YPE-0092023-12-06

    2 trial sites

  • Phase 1YPI-0102023-06-16

    2 trial sites

  • Phase 1YPI-0052022-12-29

    1 trial site

  • Bioequivalence영프로마정(프로시클리딘염산염)2022-12-12

    2 trial sites

  • Bioequivalence영진세파클러시럽2022-12-02

    2 trial sites

  • Bioequivalence세로파질건조시럽(세프프로질수화물125mg(역가)/5mL)2022-11-28

    2 trial sites

Show 22 more
  • Bioequivalence펠프스서방정45밀리그램(펠루비프로펜)2022-06-16

    2 trial sites

  • Bioequivalence펠프스서방정45밀리그램(펠루비프로펜)2022-06-10

    2 trial sites

  • BioequivalenceYPI-011 20/500mg2022-06-02

    2 trial sites

  • BioequivalenceYPI-011 10/500mg2022-06-02

    2 trial sites

  • Bioequivalence세포세틸정(세프포독심프록세틸)2022-05-20

    2 trial sites

  • Bioequivalence영진세프디토렌피복실세립10%2022-04-18

    2 trial sites

  • Phase 1YPI-0102021-11-29

    2 trial sites

  • Bioequivalence아리피진정2밀리그램(아리피프라졸(미분화))2021-10-25

    2 trial sites

  • Bioequivalence라세카캡슐100mg(라세카도트릴)2021-07-06

    2 trial sites

  • Bioequivalence자렉스정2.5밀리그램(리바록사반(미분화))2021-01-15

    2 trial sites

  • Phase 1YPI-0112021-01-05

    2 trial sites

  • Bioequivalence라세카캡슐100mg(라세카도트릴)2020-09-11

    2 trial sites

  • Phase 1YPI-0102020-04-20

    2 trial sites

  • Bioequivalence펠프스정(펠루비프로펜)2020-03-23

    2 trial sites

  • Bioequivalence영진멀타자핀정15밀리그램(미르타자핀)2019-12-10

    2 trial sites

  • Bioequivalence자렉스정20밀리그램(리바록사반(미분화))2019-11-27

    2 trial sites

  • Bioequivalence쿠티아핀정12.5밀리그램2018-12-18

    2 trial sites

  • Bioequivalence영진설트랄린정 50밀리그램2018-03-08

    2 trial sites

  • Phase 1YNP-18072017-08-29

    1 trial site

  • Phase 1KL13332017-02-02

    1 trial site

  • Phase 2YRA1909(멀꿀잎 물 건조엑스)2015-12-31

    23 trial sites

  • Phase 1YNP-17072014-01-23

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched
Show 2 more trials

R&D and key agreements

Source: DART corporate disclosure

신약 및 개량신약 개발 · Operates a Research HQ (new drug, formulation, analysis, synthesis teams) and Development HQ (RA, planning, IP, PV, clinical teams) conducting new/improved drug development and bioequivalence studies.

Key disclosures

KRX KIND via OpenDART
Show 2 more events

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 174 more patents

AI reads

MAA server logs · IP-verified
84
Times AI engines pulled YUNGJIN PHARM. CO., LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

2
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

82
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 1
Last 7 days
61
live 1
Last 30 days
84
live 2
All time
  • OpenAIChatGPT-Userlive2
  • OpenAIOAI-SearchBot75
  • GoogleGoogleOther3
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for YUNGJIN PHARM. CO., LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

NUON CO., LTD.1 shared

KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.

Hanmi Pharm. Co., Ltd.1 shared

KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).

Hugel, Inc.1 shared

Hugel is a KOSDAQ-listed pharmaceutical/CDMO company making a botulinum toxin injectable and the hyaluronic acid filler The Chaeum.

HUONS CO., LTD.1 shared

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

JETEMA Co.,Ltd.1 shared

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

HANALL BIOPHARMA CO.,LTD1 shared

KOSPI-listed pharma/biotech company co-developing the autoimmune biologics batoclimab and imeropruvate with partner Immunovant.

Hironic Co.,Ltd1 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

PharmaResearch Co., Ltd.1 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

Chong Kun Dang Pharmaceutical Corp.1 shared

Spun off and listed in 2013, Chong Kun Dang out-licensed its HDAC6 inhibitor CKD-510 to Novartis in a deal worth about KRW 1.7 trillion.

DreamCIS INC.1 shared

Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.

CELLUMED CO., LTD.1 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition